ReviewFrontiers in public health2026
Lung cancer in never-smoking females: epidemiology, risk factors and screening.
Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although smoking is a well-established risk factor, lung cancer in never-smokers exhibits distinct epidemiological and biological characteristics. Globally, approximately two-thirds of lung cancer cases in never-smokers occur in females, with a higher prevalence observed in Asian populations. Understanding these epidemiological patterns and specific risk factors holds significant implications for informing effective prevention and control strategies. In addition, low-dose CT screening for never-smoking females remains controversial due to insufficient evidence to support its benefits and unresolved concerns about overdiagnosis. This review provides a comprehensive overview of lung cancer among never-smoking females, synthesizing current evidence on its epidemiology, risk factors, and screening practices, thereby elucidating the multifaceted nature of lung cancer in this population and highlighting its implications for prevention, risk stratification, and future research priorities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.